Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Iodine Radioisotopes
  • Leukemia, Myeloid
  • Radioimmunotherapy

abstract

  • These data suggest that safe leukemic cytoreduction can be achieved with 131I-M195 even in multiply relapsed or chemotherapy-refractory leukemias. This agent may be useful as part of a preparative regimen for BMT.

publication date

  • December 1993

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 8426207

Additional Document Info

start page

  • 294

end page

  • 303

volume

  • 11

number

  • 2